Comparison of low-dose simvastatin and gemfibrozil in the treatment of elevated plasma cholesterol
- 1 October 1989
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 87, S47-S53
- https://doi.org/10.1016/s0002-9343(89)80599-6
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison between lovastatin and gemfibrozil in the treatment of primary hypercholesterolemia: The finnish multicenter studyThe American Journal of Cardiology, 1988
- Comparison of lovastatin and probucol in treatment of familial and non-familial hypercholesterolemia: different effects on lipoprotein profilesAtherosclerosis, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- Lovastatin (Mevinolin) in the Treatment of Heterozygous Familial HypercholesterolemiaAnnals of Internal Medicine, 1987
- Current pharmacologic treatment of elevated serum cholesterol.Circulation, 1987
- Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacinJournal of the American College of Cardiology, 1986
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986
- Therapeutic Response to Lovastatin (Mevinolin) in Nonfamilial HypercholesterolemiaJAMA, 1986
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- A power study of a rank transform for the two‐way classification model when interaction may be presentThe Canadian Journal of Statistics / La Revue Canadienne de Statistique, 1974